Tiverton Asset Management’s Medicines Co MDCO Stock Holding History

Tiverton Asset Management’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$250K	Buy	5,000 +1,600	+47%	+$63.8K	0.01%	510
2019 Q2	$124K	Buy	3,400 +883	+35%	+$28.8K	﹤0.01%	601
2019 Q1	$70K	Hold	2,517	–	–	﹤0.01%	614
2018 Q4	$48K	Buy	+2,517	New	+$58.6K	﹤0.01%	456
2018 Q3	–	Sell	-975	Closed	-$36K	–	432
2018 Q2	$36K	Buy	+975	New	+$31.7K	﹤0.01%	400

Other funds holding MDCO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

SPC

Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return

Tiverton Asset Management's MDCO Position: Q3 2019 in Review

Tiverton Asset Management increased its Medicines Co (MDCO) stake by 47% in Q3 2019, buying an estimated $63.8K and bringing the position to 5,000 shares worth $250K. The position accounts for 0.01% of the portfolio, ranked #510.

Tiverton Asset Management first reported a position in MDCO in Q2 2018 and has held it in 5 quarters since. 250 funds tracked by Wall St. Rank hold MDCO as of Q3 2019.

Tiverton Asset Management held 5,000 shares of Medicines Co worth $250K as of Q3 2019.
Tiverton Asset Management bought 1,600 Medicines Co shares in Q3 2019, an estimated $63.8K.
Medicines Co made up 0.01% of Tiverton Asset Management's portfolio in Q3 2019, its #510 holding.
Tiverton Asset Management first reported a position in Medicines Co in Q2 2018 and has held it in 5 quarters since.
250 funds tracked by Wall St. Rank held Medicines Co as of Q3 2019.

Based on Tiverton Asset Management's 13F filing for Q3 2019, filed 13 Nov 2019.